<DOC>
	<DOCNO>NCT01203644</DOCNO>
	<brief_summary>The primary objective study determine appropriate dose SKY0402 management postoperative pain follow inguinal hernia repair . This study evaluate safety , efficacy , pharmacokinetics SKY0402 compare 100 mg dose bupivacaine HCl treatment postoperative pain subject undergoing inguinal hernia repair . Study drug administer surgical wound infiltration end hernia repair procedure .</brief_summary>
	<brief_title>Evaluation Safety , Efficacy , Pharmacokinetics SKY0402 Subjects Undergoing Inguinal Hernia Repair</brief_title>
	<detailed_description>SKY0402 administer dose escalating/de-escalating fashion , low start dose Cohort 1 increase decrease subsequent cohort base safety analgesic effect . The decision proceed next cohort ( i.e. , increase decrease dose ) make Cohort Data Review Committee follow review data previous cohort . Subjects randomize receive either SKY0402 bupivacaine HCl ratio 1:1 Cohort 1 ratio 3:1 subsequent cohort . The dose bupivacaine HCl ( 100 mg ) remain constant cohort .</detailed_description>
	<mesh_term>Hernia</mesh_term>
	<mesh_term>Hernia , Inguinal</mesh_term>
	<mesh_term>Bupivacaine</mesh_term>
	<criteria>1 . Males â‰¥18 year age Screening visit . 2 . Scheduled undergo unilateral inguinal hernia repair general anesthesia , use open , tension free procedure ( e.g. , Lichtenstein technique without mesh ) . 3 . American Society Anesthesiology ( ASA ) Physical Class 1 2 . 4 . Able willing comply study visit procedure . 5 . Capable speak understanding local language sufficiently provide response pain assessment scale . 6 . Willing capable provide write informed consent . 1 . Clinically significant electrocardiogram abnormality Screening Day 1 ( pre administration ) . 2 . Albumin and/or alpha 1 acid glycoprotein ( AAG ) normal level . 3 . Current historical evidence clinically significant disease condition , opinion Investigator , might increase risk surgery complicate subject 's postoperative course . 4 . Opioid medication usage 7 day period precede administration study drug . 5 . Current medical condition could require treatment analgesic medication postoperative period pain surgically relate ( e.g. , rheumatoid arthritis ) . 6 . Body mass index &gt; 30 mg/kg2 . 7 . Body weight &lt; 60 kg . 8 . History hypersensitivity idiosyncratic reaction amide type local anesthetic agent . 9 . History hypersensitivity , idiosyncratic reaction , contraindication pain control agent ( opioid nonopioid ) anticipate use postoperatively . These contraindication may include : angioedema bronchospastic reactivity non steroidal anti inflammatory drug , peptic ulcer ( active within last three month ) , hepatic renal insufficiency . 10 . Coagulation disorder ongoing anticoagulation treatment . 11 . Administration investigational drug within 30 day five half life ( elimination ) , whichever longer , prior study drug administration . 12 . Suspected known history substance abuse and/or alcoholism . 13 . Clinically significant complication hernia repair surgery ( e.g. , excessive bleeding ) , might render subject medically unstable might complicate subject 's postoperative course .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>Postoperative pain</keyword>
	<keyword>Analgesia</keyword>
</DOC>